Colgate-Palmolive (NYSE:CL) Director John Cahill Sells 4,170 Shares

Key Points

• Director John Cahill sold 4,170 Colgate-Palmolive shares at an average price of $93.37, generating approximately $389,353. His remaining 28,373 shares are valued at about $2.65 million, a 12.81% reduction in ownership.
• Colgate-Palmolive reported quarterly EPS of $0.99, beating estimates by $0.04, while revenue reached $5.36 billion, up 4.9% year over year.
• The company declared a quarterly dividend of $0.53, equivalent to an annualized $2.12 payout and a 2.3% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $99.

Colgate-Palmolive Company (NYSE:CL - Get Free Report) Director John Cahill sold 4,170 shares of the business's stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Colgate-Palmolive Price Performance

NYSE:CL traded up $0.24 during mid-day trading on Friday, hitting $93.24. 3,738,700 shares of the company's stock traded hands, compared to its average volume of 5,985,314. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.30 and a current ratio of 1.03. The firm's 50 day simple moving average is $91.07 and its 200 day simple moving average is $89.72. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a market cap of $74.33 billion, a PE ratio of 37.00, a price-to-earnings-growth ratio of 4.56 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.04. The company had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company's revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.92 earnings per share. Sell-side analysts expect that Colgate-Palmolive Company will post 3.86 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive's dividend payout ratio is presently 84.13%.

Analyst Ratings Changes

CL has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Monday. Morgan Stanley restated an "overweight" rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a research report on Monday. Citigroup lifted their price objective on Colgate-Palmolive from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Barclays boosted their target price on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. Finally, Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $92.00 to $95.00 and gave the company an "equal weight" rating in a report on Wednesday, July 8th. Twelve analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $99.00.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in CL. Teacher Retirement System of Texas increased its stake in shares of Colgate-Palmolive by 35.3% during the fourth quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company's stock valued at $37,110,000 after acquiring an additional 122,634 shares during the period. Flputnam Investment Management Co. boosted its stake in Colgate-Palmolive by 7.4% during the 4th quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company's stock valued at $15,881,000 after purchasing an additional 13,804 shares in the last quarter. SEB Asset Management AB acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at $91,149,000. Caprock Group LLC lifted its holdings in shares of Colgate-Palmolive by 116.5% in the fourth quarter. Caprock Group LLC now owns 64,808 shares of the company's stock valued at $5,121,000 after buying an additional 34,879 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in Colgate-Palmolive by 10.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 221,443 shares of the company's stock valued at $17,498,000 after buying an additional 21,109 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source